People · Operator

Jim Goodlett

Named in public records as an officer, director or promoter · active 2009–2009 · Other Technology

1
Companies
1
Filings
$3.2M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Ingenious Med IncOther TechnologySeed$3.2M$34.1M2009
Operator network

Jim Goodlett at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Mark A Buffington · 4 companies · 1 sharedMark A BuffingtonS. Hart Williford · 2 companies · 1 sharedS. Hart WillifordGeorge Karahalis · 1 companies · 1 sharedGeorge KarahalisGrant G. Jackson · 1 companies · 1 sharedGrant G. JacksonHoward G. Morrison · 1 companies · 1 sharedHoward G. MorrisonMark B. Adams · 1 companies · 1 sharedMark B. AdamsMark B. Buffington · 1 companies · 1 sharedMark B. BuffingtonMark Chapman · 1 companies · 1 sharedMark ChapmanMark G. Buffington · 1 companies · 1 sharedMark G. BuffingtonMark G. Chapman · 1 companies · 1 sharedMark G. ChapmanMichael G. Pickering · 1 companies · 1 sharedMichael G. Picker…Steven Liu · 1 companies · 1 sharedSteven LiuSteven T. Liu · 1 companies · 1 sharedSteven T. LiuThomas G. Givens · 1 companies · 1 sharedThomas G. GivensIngenious Med Inc · $3.2M raisedIngenious Med IncJim GoodlettJG
Jim Goodlett Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Jim Goodlett on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Mark A Buffington14
S. Hart Williford12
Michael G. Pickering11
Steven T. Liu11
George Karahalis11
Grant G. Jackson11
Steven Liu11
Mark G. Chapman11
Mark G. Buffington11
Howard G. Morrison11
Thomas G. Givens11
Mark B. Buffington11
Mark B. Adams11
Mark Chapman11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.